Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Nov 29, 2016, 07:30 ET BiondVax Phase 2b Trial Preliminary Safety Results: The Universal Flu Vaccine Candidate is Safe and Well Tolerated

BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV, TASE: BVXV) today announced positive preliminary safety results from its European Phase 2b clinical...


Nov 29, 2016, 07:13 ET Edison Issues ADR Update on Celyad (CYAD)

Celyad has noted that the Phase I safety study on its NKR-2 CAR T-cell autologous therapy produced some "reports of clinical benefit". The THINK...


Nov 29, 2016, 07:00 ET CytRx Reports Statistically Significant Updated Results from Pivotal Phase 3 Trial of Aldoxorubicin in Patients with Second-Line Soft Tissue Sarcomas

CytRx Corporation (NASDAQ:CYTR) today announced positive updated results from its pivotal Phase 3 clinical trial evaluating aldoxorubicin compared...


Nov 29, 2016, 05:00 ET Alcohol Consumption Shows No Effect on Coronary Arteries

Researchers using coronary computed tomography angiography (CCTA) have found no association between light to moderate alcohol consumption and...


Nov 29, 2016, 05:00 ET Depression in Soldiers Linked to Brain Disruption from Injury

Using multiple brain imaging techniques, researchers have found that a disruption of the circuitry in the brain's cognitive-emotional...


Nov 29, 2016, 04:00 ET Pharmalink Announces European Orphan Drug Designation For Nefecon® For Treatment Of Iga Nephropathy, An Inflammatory Kidney Disease

Pharmalink AB, a specialty pharma company, announces that the European Commission (EC) has granted Orphan Medicinal Product (OMP) designation in...


Nov 28, 2016, 18:01 ET Blueprint Medicines Announces Proof-of-Concept Data from Global Phase 1 Clinical Trial of BLU-554 in Patients with Advanced Hepatocellular Carcinoma

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically...


Nov 28, 2016, 16:45 ET DATATRAK Releases Powerful Clinical Trial Management System

DATATRAK International, Inc. (OTCQX: DTRK), has released their innovative clinical trial management system, CTMS 360°. DATATRAK's CTMS is a robust,...


Nov 28, 2016, 16:05 ET Jazz Pharmaceuticals Announces That Patient Enrollment is Complete for the Phase 3 Study of JZP-110 Evaluating Excessive Sleepiness in Narcolepsy

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that patient enrollment has been completed in its Phase 3 study evaluating JZP-110 in...


Nov 28, 2016, 12:00 ET Worldwide Clinical Trials Webinar to Address Emerging Trends in Clinical Trial Methodology for Orphan Disease Drug Development

Worldwide Clinical Trials (http://www.worldwide.com ) will present a webinar, titled "Necessity is the Mother of Invention: The Impetus for...


Nov 28, 2016, 10:43 ET Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial Of MiStent In Japan

Micell Technologies, Inc. (Micell) announced enrollment of the first patient in DESSOLVE J: a prospective, randomized, balanced, controlled,...


Nov 28, 2016, 10:07 ET ImMAGE Biotherapeutics Announces Positive Results from Animal Studies

ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company, announced today that is has successfully completed animal trials. The...


Nov 28, 2016, 09:41 ET New Data and Analyses on FYCOMPA and BANZEL at American Epilepsy Society Meeting Demonstrate Eisai's Continued Commitment to the Epilepsy Community

Eisai Inc. announced today the presentation of 12 posters during the 70th annual American Epilepsy Society (AES) Annual Meeting, highlighting data...


Nov 28, 2016, 09:05 ET PharmaMar Begins a Phase I Study of PM1183 in Japan for the Treatment of Solid Tumors

PharmaMar (MCE:PHM) has announced the start of an open-label, multicenter, Phase I study in Japan to evaluate the recommended dose (RD) of PM1183...


Nov 28, 2016, 09:00 ET Nature Cell Co., Ltd. Receives U.S. FDA Approval for Phase I and II Alzheimer's Clinical Trial

Nature Cell Co., Ltd. (Nature Cell) (CEO, Dr. Jeongchan Ra), a leading biotechnology company, announces AstroStem's approval for Phase I and Phase...


Nov 28, 2016, 08:30 ET Foamix Announces Completion of Patient Enrollment in Phase 3 Acne Trials for Minocycline Foam FMX101

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) ("Foamix" or the "Company"), a clinical stage specialty pharmaceutical company focused on developing and...


Nov 28, 2016, 08:08 ET BiondVax Announces Third Quarter 2016 Financial Results and Update

BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV, TASE: BVXV), a clinical stage biopharmaceutical company focused on developing and commercializing a...


Nov 28, 2016, 08:00 ET Case Studies by Charles K. Lee, MD, FACS, Clearly Validates Efficacy and Safety of Medela's NPWT Devices

Medela Healthcare proudly presents the results of a case series which prove the clinical efficacy of Medela's Invia® Liberty™ and...


Nov 28, 2016, 08:00 ET MabVax Therapeutics Enrolls First Patients in Expansion of Phase I Clinical Trial Treating Newly Diagnosed Pancreatic Cancer Patients

MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX), a clinical stage immuno-oncology drug development company, reported that the first patients have...


Nov 28, 2016, 08:00 ET Emerald Medical Application's Dermacompare Technology Chosen as One of Four Start Up Technology Winners of Merck's Health Innovation Technology Scouts (HITS) Program

Emerald Medical Applications Corp. (OTCQB: MRLA) ("Emerald" or the "Company"), the Israeli-based company engaged in the development and sale of...


Most Viewed